Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ebola
Sort By
Newest First
1 / 1
FDA Approval
FDA Approves First Treatment for Ebola Virus
U.S. Food & Drug Administration
PR-M10-20-10
Oct 15, 2020
Priority Review
FDA Accepts for Priority Review Biologics License Application for REGN-EB3 to Treat Ebola
Regeneron
PR-M04-20-NI-025
Apr 17, 2020
Ebola Vaccine
FDA Approves First Vaccine for the Prevention of Ebola Virus Disease
U.S. Food & Drug Administration
PR-M12-19-NI-035
Dec 20, 2019
Vaccine
Gavi Board Approves New Ebola Vaccine Program
Gavi, The Vaccine Alliance
PR-M12-19-NI-011
Dec 05, 2019
Vaccine Approval
Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union
Merck & Co.
PR-M11-19-NI-011
Nov 13, 2019
Diagnostics
FDA Allows Marketing of First Rapid Diagnostic Test for Detecting Ebola Virus Antigens
U.S. Food & Drug Administration
PR-M10-19-NI-019
Oct 11, 2019
Vaccine
Uganda Starts its Largest-Ever Ebola Vaccine Trial
Nice Insight
PR-M08-19-NI-018
Aug 07, 2019
Crisis
No International Ebola Crisis Declared Yet
Pharma's Almanac
PAO-M04-19-NI-023
Apr 18, 2019
Vaccine
Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases
Inovio Pharmaceuticals, Inc.
PR-M03-19-NI-072
Mar 26, 2019
Vaccine
Soligenix Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate
Soligenix, Inc.
PR-M02-19-NI-023
Feb 11, 2019
Clinical Study
Clinical Study Explores the Efficacy of Numerous Ebola Therapies
Emilie Branch
Pharma's Almanac
PAO-M11-18-NI-029
Nov 28, 2018
Vaccine
Merck, J&J Receive BARDA Funding for Ebola Vaccine Development
Emilie Branch
Pharma's Almanac
PAO-M10-17-NI-019
Oct 13, 2017
Partnership
Academic-Industry Partnership Receives Funds to Develop Ebola Vaccine
Emilie Branch
Pharma's Almanac
PAO-M08-17-NI-021
Aug 15, 2017
1 / 1
